Brief: Oncopeptides, Vector Pharma Partner To Provide Pepaxti To Patients In MENA Region

Oncopeptides AB

27/03/2024 12:31

March 27 (Reuters) - 
    Oncopeptides and Vector Pharma FZCO:
  
    * ONCOPEPTIDES AND VECTOR PHARMA FZCO ANNOUNCE COLLABORATION
TO
PROVIDE PEPAXTI TO PATIENTS IN THE MIDDLE EAST AND NORTH AFRICA
    * ONCOPEPTIDES AB: UNDER TERMS OF AGREEMENT, VECTOR TO
DISTRIBUTE
PEPAXTI TO PATIENTS IN MENA REGION FOR TREATMENT OF PATIENTS
WITH MULTIPLE MYELOMA
    * ONCOPEPTIDES AB: PARTIES HAVE AGREED ON REVENUE SPLIT ON
ALL
PEPAXTI SALES IN MENA, WITH VECTOR CARRYING ALL COSTS THROUGH
EXISTING STRUCTURE IN MENA

Source text for Eikon:  ID:nGNX4dRrFF 
Further company coverage:  ONCO.ST 

 ((Reuters.Briefs@thomsonreuters.com;))